麻醉阻断了大鼠对巴罗受体卸载的心血管反应
Michelle L Nieman1, Srikumaran Sakthivel2, Bryan Mackenzie1
1Department of Pharmacology, Physiology and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, OH.
Function (Oxford, England)
|December 16, 2025
概括
常见的麻醉剂阻断了在静止性压力期间维持血压所必需的巴罗反射. 这项研究发现,即使是静脉注射的尿也只能在部分情况下保持大鼠的血压反应.
科学领域:
- 生理学 生理学 生理学
- 麻醉学 麻醉学
- 心血管研究研究心血管研究
背景情况:
- 巴罗反射反应对于在静止压力期间维持血压至关重要.
- 由于麻醉的要求,在清醒的动物中评估巴罗反射是具有挑战性的.
- 之前的研究表明,3%的异氨酸阻断了老鼠的气息反射.
研究的目的:
- 研究各种常见麻醉剂在小鼠下体负压 (LBNP) 时对巴罗反射反应的影响.
- 扩展先前关于异氨酸对气体反射的影响的发现.
- 为了比较不同麻醉剂和施用方法的效果.
主要方法:
- 在清醒的雄性和雌性大鼠中,评估血压 (BP) 和心率 (HR) 对分级LBNP的反应.
- 在不同的麻醉方案下重复测量:多巴尔比他,胺/西拉,异氨酸 (3%,2%,1.5%) 和尿 (玻尿酸,缓慢的脉动力). 输液,缓慢的静脉输液. 输液). 这就是输液.
主要成果:
- 醒着的老鼠保持血压高达-15 mmHg LBNP,心跳缓慢反应强烈.
- 所有测试的麻醉剂都严重或完全阻断了LBNP和反射低心率期间的BP维护.
- 静脉注射尿在LBNP期间部分保留了BP反应,但不是反射性心动减速.
结论:
- 通常使用的麻醉剂消除了在静止挑战期间维持血压的功能性巴罗反射.
- 麻醉显著损害了维持血液动力学稳定的生理补偿机制.
- 与其他麻醉剂相比,静脉注射尿提供了最小的血压反应保护.
更多相关视频
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10.8K
09:37Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
15.4K
相关概念视频
01:18Neural Regulation of Blood Pressure
6.7K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.7K
01:22Heart Failure Drugs: β-Blockers
729
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
729
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.5K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
01:16Antianginal Drugs: Nitrates and β-Blockers
1.3K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.3K